Influence of Chronic Phenytoin Administration on the Pharmacokinetics and Pharmacodynamics of Vecuronium

Anesthesiology

Volumn 100, Issue 3, 2004, Pages 626-633

  Wright, Peter M C ^a,d   McCarthy, Gerald ^a,b   Szenohradszky, Janos ^a,c   Sharma, Manohar L ^d   Caldwell, James E ^a  

^a Department of Anesthesia ^*  (United States)

^b BELFAST CITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 DEACETYLVECURONIUM; DRUG METABOLITE; PHENYTOIN; UNCLASSIFIED DRUG; VECURONIUM;

ADULT; CAPILLARY GAS CHROMATOGRAPHY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISPOSITION; DRUG METABOLISM; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

ADULT; ANTICONVULSANTS; BIOTRANSFORMATION; CRANIOTOMY; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PHENYTOIN; SUPRATENTORIAL NEOPLASMS; VECURONIUM BROMIDE;

EID: 1442332762     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200403000-00024     Document Type: Conference Paper

References (36)

1. Kumar CM, Lawler PG: Phenytoin-induced resistance to vecuronium. Anaesthesia 1989; 44:263-4
2. Ornstein E, Matteo RS, Schwartz AE, Silverberg PA, Young WL, Diaz J: The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium. ANESTHESIOLOGY 1987; 67:191-6
3. Tempelhoff R, Modica PA, Jellish WS, Spitznagel EL: Resistance to atracurium-induced neuromuscular blockade in patients with intractable seizure disorders treated with anticonvulsants. Anesth Analg 1990; 71:665-9
4. Hickey DR, Sangwan S, Bevan JC: Phenytoin-induced resistance to pancuronium: Use of atracurium infusion in management of a neurosurgical patient. Anaesthesia 1988; 43:757-9
5. Jellish WS, Modica PA, Tempelhoff R: Accelerated recovery from pipecuronium in patients treated with chronic anticonvulsant therapy. J Clin Anesth 1993; 5:105-8
6. Szenohradszky J, Caldwell JE, Sharma ML, Gruenke LD, Miller RD: Interaction of rocuronium (ORG 9426) and phenytoin in a patient undergoing cadaver renal transplantation: A possible pharmacokinetic mechanism? ANESTHESIOLOGY 1994; 80:1167-70
7. Norris FH, Colella J, McFarlin D: Effect of diphenylhydantoin on neuromuscular synapse. Neurology 1964; 14:869-76
8. Martyn JA, White DA, Gronert GA, Jaffe RS, Ward JM: Up-and-down regulation of skeletal muscle acetylcholine receptors: Effects on neuromuscular blockers. ANESTHESIOLOGY 1992; 76:822-43
9. Furuta T, Canfell PC, Castagnoli KP, Sharma ML, Miller RD: Quantitation of pancuronium, 3-desacetylpancuronium, vecuronium, 3-desacetylvecuronium, pipecuronium and 3-desacetylpipecuronium in biological fluids by capillary gas chromatography using nitrogen-sensitive detection. J Chromat 1988; 427:41-53
10. Caldwell JE, Szenohradszky J, Segredo V, Wright PM, McLoughlin C, Sharma ML, Gruenke LD, Fisher DM, Miller RD: The pharmacodynamics and pharmacokinetics of the metabolite 3-desacetylvecuronium (ORG 7268) and its parent compound, vecuronium, in human volunteers. J Pharmacol Exp Ther 1994; 270:1216-22
11. Holford NH, Sheiner LB: Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet 1981; 6:429-53
12. Holford NH, Sheiner LB: Kinetics of pharmacologic response. Pharmacol Ther 1982; 16:143-66
13. Gray HS, Slater RM, Pollard BJ: The effect of acutely administered phenytoin on vecuronium-induced neuromuscular blockade. Anaesthesia 1989; 44: 379-81
14. Spacek A, Nickl S, Neiger FX, Nigrovic V, Ullrich OW, Weindmayr-Goettel M, Schwall B, Taeger K, Kress HG: Augmentation of the rocuronium-induced neuromuscular block by the acutely administered phenytoin. ANESTHESIOLOGY 1999; 90:1551-5
15. Platt PR, Thackray NM: Phenytoin-induced resistance to vecuronium. Anaesth Intensive Care 1993; 21:185-91
16. Hans P, Brichant JF, Pieron F, Pieyns P, Born JD, Lamy M: Elevated plasma alpha 1-acid glycoprotein levels: lack of connection to resistance to vecuronium blockade induced by anticonvulsant therapy. J Neurosurg Anesthesiol 1997; 9:3-7
17. Koenig HM, Hoffman WE: The effect of anticonvulsant therapy on two doses of rocuronium-induced neuromuscular blockade. J Neurosurg Anesthesiol 1999; 11:86-9
18. Liberman BA, Norman P, Hardy BG: Pancuronium-phenytoin interaction: a case of decreased duration of neuromuscular blockade. Int J Clin Pharmacol Ther 1988; 26:371-4
19. Soriano SG, Kaus SJ, Sullivan LJ, Martyn JA: Onset and duration of action of rocuronium in children receiving chronic anticonvulsant therapy. Paediatr Anaesth 2000; 10:133-6
20. Soriano SG, Sullivan LJ, Venkatakrishnan K, Greenblatt DJ, Martyn JA: Pharmacokinetics and pharmacodynamics of vecuronium in children receiving phenytoin or carbamazepine for chronic anticonvulsant therapy. Br J Anaesth 2001; 86:223-9
21. Alloul K, Whalley DG, Shutway F, Ebrahim Z, Varin F: Pharmacokinetic origin of carbamazepine-induced resistance to vecuronium neuromuscular blockade in anesthetized patients. ANESTHESIOLOCY 1996; 84:330-9
22. Hans P, Ledoux D, Bonhomme V, Brichant JF: Effect of plasma anticonvulsant level on pipecuronium-induced neuromuscular blockade: preliminary results. J Neurosurg Anesthesiol 1995; 7:254-8
23. Spacek A, Neiger FX, Krenn CG, Hoerauf K, Kress HG: Rocuronium-induced neuromuscular block is affected by chronic carbamazepine therapy. ANESTHESIOLOGY 1999; 90:109-12
24. Whalley DG, Ebrahim Z: Influence of carbamazepine on the dose-response relationship of vecuronium. Br J Anaesth 1994; 72:125-6
25. Driessen JJ, Robertson EN, Booij LH, Vree TB: Accelerated recovery and disposition from rocuronium in an end-stage renal failure patient on chronic anticonvulsant therapy with sodium valproate and primidone. Br J Anaesth 1998; 80:386-8
26. Ornstein E, Matteo RS, Young WL, Diaz J: Resistance to metocurine-induced neuromuscular blockade in patients receiving phenytoin. ANESTHESIOLOGY 1985; 63:294-8
27. Ornstein E, Matteo RS, Weinstein JA, Halevy JD, Young WL, Abou-Donia MM: Accelerated recovery from doxacurium-induced neuromuscular blockade in patients receiving chronic anticonvulsant therapy. J Clin Anesthesiol 1991; 3:108-11
28. Jellish WS, Thalji Z, Brundidge PK, Tempelhoff R: Recovery from mivacurium-induced neuromuscular blockade is not affected by anticonvulsant therapy. J Neurosurg Anesthesiol 1996; 8:4-8
29. Spacek A, Neiger FX, Spiss CK, Kress HG: Atracurium-induced neuromuscular block is not affected by chronic anticonvulsant therapy with carbamazepine. Acta Anaesthesiol Scand 1997; 41:1308-11
30. Bencini AF, Scaf AH, Sohn YJ, Kersten-Kleef UW, Agoston S: Hepatobiliary disposition of vecuronium bromide in man. Br J Anaesth 1986; 58:988-95
31. Gage PW, Lonergan M, Torda TA: Presynaptic and postsynaptic depressant effects of phenytoin sodium at the neuromuscular junction. Br J Pharmacol 1980; 69:119-21
32. Gandhi IC, Jindal MN, Patel VK: Mechanism of neuromuscular blockade with some antiepileptic drugs. Arzneimittelforschung 1976; 26:258-61
33. Kim CS, Arnold FJ, Itani MS, Martyn JA: Decreased sensitivity to metocurine during long-term phenytoin therapy may be attributable to protein binding and acetylcholine receptor changes. ANESTHESIOLOGY 1992; 77:500-6
34. Melton AT, Antognini JF, Gronert GA: Prolonged duration of succinylcholine in patients receiving anticonvulsants: Evidence for mild up-regulation of acetylcholine receptors? Can J Anaesth 1993; 40:939-42
35. Wright PM: Population based pharmacokinetic analysis: Why do we need it; what is it; and what has it told us about anaesthetics? Br J Anaesth 1998; 80:488-501
36. Boeckman AJ, Beal SL, Sheiner LB: NONMEM Users Guide Version V. San Francisco, NONMEM Project Group, University of California at San Francisco, 1997